MAKING PROTEINS ACCESSIBLE
LIVE

Serial Number

79377404

Owner

Nuclera Ltd

Attorney

Rebecca Liebowitz

Filing Date

May 10, 2023

Add to watchlist:

No watchlists yet
View on USPTO

MAKING PROTEINS ACCESSIBLE Trademark

Serial Number: 79377404 • Registration: 7582985

MAKING PROTEINS ACCESSIBLE is a trademark filed by Nuclera Ltd on May 10, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Nuclera Ltd (9 trademarks)

One Vision Park,

Entity Type: 99

Trademark Details

Filing Date

May 10, 2023

Registration Date

December 3, 2024

Published for Opposition

October 1, 2024

Goods & Services

Scientific laboratory apparatus and instruments, namely, scientific desktop instruments for DNA, RNA, gene and protein synthesis for scientific use; scientific desktop instruments for DNA, RNA, gene and protein synthesis, namely, microfluidic devices; cartridges containing biological samples for use in scientific apparatus in connection with DNA, RNA, gene, cell and protein synthesis and characterization instruments, namely microfluidic devices; semiconductors; semiconductor chips; microchips; bio sensors in the nature of sensor chips for scientific, research or industrial purposes in DNA, RNA, gene and protein synthesis; biochips in the nature of microchips; scientific research and laboratory apparatus, namely, apparatus and instruments for amplifying DNA and RNA, namely, reactors, bioreactors, and laboratory apparatus and instruments for amplifying DNA and RNA using thermocyclers, not for medical purposes; apparatus and instruments for synthesising DNA and RNA, namely, microarrays, scientific desktop instruments, desktop instrument cartridges, semiconductors, semiconductor chips, microchips, bio sensors, and bio-chips, not for medical purposes; scientific research and laboratory apparatus, namely, apparatus and instruments for processing DNA and RNA, namely scientific desktop instruments, desktop instrument cartridges, semiconductors, semiconductor chips, microchips, biosensors, and biochips; computer hardware; recorded computer software, downloadable computer software and downloadable bioinformatics software for use in DNA, RNA, gene and protein synthesis in the fields of biotechnology, drug discovery and medical science

Medical apparatus and instruments used for DNA and RNA testing and analysis and genetic testing, all for medical purposes; apparatus and instruments for DNA and RNA analysis, DNA and RNA sequencing and protein synthesis in the nature of microfluidic chips, microfluidic cartridges, micro-electromechanical chips, bio sensors, and bio-chips for medical and veterinary purposes; apparatus for DNA, RNA, gene and protein synthesis in the nature of microfluidic chips, microfluidic cartridges, micro-electromechanical chips, bio sensors, and bio-chips for medical and veterinary purposes

Chemical preparations for scientific purposes; chemical preparations, enzymes, gene editing enzymes, oligonucleotides, and proteins for scientific and industrial purposes; genes, DNA and RNA being nucleic acid sequences for scientific and industrial purposes; nucleic acids comprising natural and synthetic nucleotides and oligonucleotides for scientific and industrial purposes; synthetic DNA, synthetic RNA and synthetic genes being nucleic acid sequences for scientific and industrial purposes; synthetic oligonucleotides and synthetic proteins for scientific and industrial use; chemicals, reagents and enzymes for use in the preparation and creation of synthetic DNA, synthetic RNA, synthetic genes being nucleic acid sequences for scientific and industrial purposes; molecular biology research tools in the nature of biological and biochemical reagents; molecular biology research tools in the nature of chemical, biological and biochemical reagents used for the synthesis of DNA, RNA, oligonucleotides, genes and proteins for scientific and industrial purposes

Biological, chemical and biochemical reagents, namely, proteins, and gene editing enzymes, all for medical diagnostic use; synthetic proteins for medical diagnostic use; vaccines

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
May 24, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 5, 2025 FICS
FINAL DISPOSITION PROCESSED
May 5, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 3, 2025 FICR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 1, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 1, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 1, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 1, 2025 REAP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 15, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 27, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 26, 2025 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 3, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 3, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 1, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 1, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 11, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 23, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 9, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 9, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 9, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 9, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 9, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 9, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 9, 2024 TROA
REFUSAL PROCESSED BY IB
Apr 2, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 11, 2024 RFCS
REFUSAL PROCESSED BY MPU
Mar 11, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 10, 2024 RFCR
NON-FINAL ACTION WRITTEN
Feb 10, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 5, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 5, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 1, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 31, 2023 REPR